WebFeb 24, 2024 · Jeffrey D. Marrazzo, the co-founder of Spark Therapeutics, guided the company to the launch of the world’s first regulatory-approved gene therapy for genetic diseases and helmed the company’s merger with Swiss pharma giant Roche. Now, he is stepping down from his role as CEO. Ron Philip, Spark’s COO, will take over the role. WebFeb 25, 2024 · Jeff Marrazzo’s Big, Bold Philly Gene Therapy Vision The self-described science novice led Spark Therapeutics from start-up obscurity to the pinnacle of medicine …
Media – Spark Therapeutics
WebDec 11, 2024 · Jeffrey D. Marrazzo C00 G00 WG03. 39; co-founder and CEO, Spark Therapeutics, Inc.; led Spark’s transition from a Children’s Hospital of Philadelphia … WebFeb 10, 2024 · Jeff Marrazzo, the former CEO of Philadelphia-based Spark Therapeutics and a member of the innovation subcommittee of Gov. Josh Shapiro’s transition team, has several ideas on how Pennsylvania’s new governor can support the state’s innovation economy, particularly companies in biotechnology and life sciences, writes Harold … recycling fabric
Works begins on Spark Therapeutics $575M gene therapy …
WebSep 27, 2024 · Jeffrey Marrazzo is based out of Philadelphia, Pennsylvania, United States and works at Spark Therapeutics, Inc. as Chief Executive Officer and Co-Founder. Reveal … WebPHILADELPHIA, Feb. 25, 2024 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of $114.50 per share … WebFeb 23, 2024 · Under Jeff Marrazzo’s leadership, Spark launched world’s first FDA-approved gene therapy for a genetic disease. He also spearheaded Spark’s $4.8 billion acquisition … klb mathematics book 1 teachers guide